FORT ST. JOHN, B.C. — A local business raised $2,500 for multiple sclerosis (MS) research. KJA Ventures hosted its first community barbecue at its storefront on Friday, May 30th, for MS Canada to mark ...

Panelists discuss how chronic neuroinflammation involves distinct mechanisms from acute relapses—including microglial ...

While it trails Johnson & Johnson’s Tecvayli, Regeneron still hopes Lynozyfic can differentiate in terms of dosing ...

While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type 1 diabetes, hepatitis ...

Many people with multiple sclerosis (MS) may wonder whether trying a certain diet — or eliminating a certain food group from their diet — can ward off MS symptoms, like fatigue or cognitive ...

AbbVie (ABBV) on Monday announced that it has entered into a definitive agreement to acquire privately held clinical-stage ...

1 Introduction Multiple sclerosis (MS) is a chronic, immune-mediated disease of the central nervous system (CNS) which affects an estimated 2.8 million people worldwide (1). With the average age of ...

Birmingham has a very strong history of immunology research going back 30 years, and with one of the greatest concentrations of scientists and doctors in the world is well positioned to make a ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...